A carregar...

Role of Immunotherapy for Renal Cell Cancer in 2011

High-dose interleukin-2 (HD IL-2) and interferon were the most commonly administered therapies before the recent introduction of targeted agents, including vascular endothelial growth factor and mammalian target of rapamycin pathway inhibitors. Although the new agents result in a progression-free su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: George, Saby, Pili, Roberto, Carducci, Michael A., Kim, Jenny J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4020430/
https://ncbi.nlm.nih.gov/pubmed/21917625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!